| 000 | 01611 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512115823.0 | ||
| 264 | 0 | _c19720929 | |
| 008 | 197209s 0 0 eng d | ||
| 022 | _a0031-3955 | ||
| 024 | 7 |
_a10.1016/s0031-3955(16)32667-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJuchau, M R | |
| 245 | 0 | 0 |
_aPharmacology of the placenta. _h[electronic resource] |
| 260 |
_bPediatric clinics of North America _cFeb 1972 |
||
| 300 |
_a65-79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmine Oxidase (Copper-Containing) _xpharmacology |
| 650 | 0 | 4 |
_aAminopeptidases _xpharmacology |
| 650 | 0 | 4 |
_aAnalgesics _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHaplorhini |
| 650 | 0 | 4 |
_aHistamine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aLysergic Acid Diethylamide _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xmetabolism |
| 650 | 0 | 4 |
_aPlacenta _xblood supply |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerotonin _xpharmacology |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 |
_aUmbilical Arteries _xdrug effects |
| 650 | 0 | 4 |
_aUmbilical Veins _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aDyer, D C | |
| 773 | 0 |
_tPediatric clinics of North America _gvol. 19 _gno. 1 _gp. 65-79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0031-3955(16)32667-0 _zAvailable from publisher's website |
| 999 |
_c4629878 _d4629878 |
||